These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27126081)

  • 41. Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway.
    Liu X; Wang L; Chen J; Ling Q; Wang H; Li S; Li L; Yang S; Xia M; Jing L
    Mol Med Rep; 2015 Feb; 11(2):1516-22. PubMed ID: 25351348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
    Lan F; Yu H; Hu M; Xia T; Yue X
    J Neurochem; 2015 Oct; 135(2):274-86. PubMed ID: 26250785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death.
    Kahn SA; Biasoli D; Garcia C; Geraldo LH; Pontes B; Sobrinho M; Frauches AC; Romão L; Soletti RC; Assunção Fdos S; Tovar-Moll F; de Souza JM; Lima FR; Anderluh G; Moura-Neto V
    Curr Top Med Chem; 2012; 12(19):2082-93. PubMed ID: 23167797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
    Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
    Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men.
    Hu L; Jin Y; Li YG; Borel A
    Clin Pharmacol Drug Dev; 2015 Jul; 4(4):305-14. PubMed ID: 27136911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo.
    Kavitha CV; Jain AK; Agarwal C; Pierce A; Keating A; Huber KM; Serkova NJ; Wempe MF; Agarwal R; Deep G
    Mol Carcinog; 2015 Nov; 54(11):1417-29. PubMed ID: 25252179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
    D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
    Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.
    Zeng L; Kang C; Di C; Fee BE; Rivas M; Lin J; Adamson DC
    Int J Oncol; 2014 Apr; 44(4):1243-51. PubMed ID: 24481586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
    Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
    Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.
    Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H
    Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
    Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
    Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.
    Lefranc F; James S; Camby I; Gaussin JF; Darro F; Brotchi J; Gabius J; Kiss R
    J Neurosurg; 2005 Apr; 102(4):706-14. PubMed ID: 15871514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
    Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
    J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.
    Marrero L; Wyczechowska D; Musto AE; Wilk A; Vashistha H; Zapata A; Walker C; Velasco-Gonzalez C; Parsons C; Wieland S; Levitt D; Reiss K; Prakash O
    Neoplasia; 2014 Oct; 16(10):874-82. PubMed ID: 25379024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Volpin F; Casaos J; Sesen J; Mangraviti A; Choi J; Gorelick N; Frikeche J; Lott T; Felder R; Scotland SJ; Eisinger-Mathason TSK; Brem H; Tyler B; Skuli N
    Oncogene; 2017 May; 36(21):3037-3047. PubMed ID: 27941882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
    Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
    Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
    Redjal N; Zhu Y; Shah K
    Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.